A New Drug For A Relentless Brain Disease

For years, renewable energy companies have faced a problem: How to store the mass amounts of energy they produce for later use. Batteries may be just the solution. In California, there's now enough grid-scale battery storage to power millions of homes for a few hours. Battery pow ...  عرض المزيد

Nearly every person will experience at least one diagnostic error in their lifetime. That means either a delayed diagnosis, a wrong diagnosis – or no diagnosis at all. That’s according to a report by the National Academies of Sciences, Engineering and Medicine from 2015 on diagno ...  عرض المزيد

ALS is a fatal neurological disease that kills motor neurons. Even though it was first described more than 150 years ago, there is no cure, and the few drugs available only dampen the symptoms or slow the progression by a few months. In recent years new drugs have emerged. How ...

For many years, pharmaceutical companies have tried and failed to find a treatment to slow symptoms of ALS–the debilitating, fatal illness also known as Lou Gehrig’s Disease. A potentially promising new drug from Biogen may offer some relief to those afflicted with an uncommon an ...  عرض المزيد

Last year, researchers announced that the Alzheimer’s drug lecanemab lowered the amount of amyloid protein plaques associated with the disease in the brains of participants in a clinical trial, and slowed their cognitive decline.Now, researchers are looking to drug combinations, ...  عرض المزيد

A new drug, Donanemab, has been hailed as a turning point in the fight against Alzheimer's after a global trial confirms it slows cognitive decline.One trial was shown to have “significantly slowed” the progression of the disease—by 35%.Earlier this year, Lecanemab, the first dru ...  عرض المزيد